“She just told me to leave it”: Women's experiences discussing early elective IUD removal

Contraception

Volumn 94, Issue 4, 2016, Pages 357-361

  Amico, Jennifer R ^a   Bennett, Ariana H ^b   Karasz, Alison ^b   Gold, Marji ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Discontinuation; Family medicine center; Intrauterine device; Qualitative

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOATING; COPPER INTRAUTERINE DEVICE; DEVICE REMOVAL; DOCTOR PATIENT RELATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL RECORD REVIEW; MUSCLE CRAMP; MYCOSIS; PAIN; PATIENT SATISFACTION; QUALITATIVE RESEARCH; SELF REPORT; SEMI STRUCTURED INTERVIEW; TREATMENT REFUSAL; URINARY TRACT INFECTION; VAGINA DISCHARGE; ADVERSE EFFECTS; GROUNDED THEORY; HEMORRHAGE; INTERVIEW; PATIENT PREFERENCE; PSYCHOLOGY; TIME FACTOR; YOUNG ADULT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; DEVICE REMOVAL; FEMALE; GROUNDED THEORY; HEMORRHAGE; HUMANS; INTERVIEWS AS TOPIC; INTRAUTERINE DEVICES; PAIN; PATIENT PREFERENCE; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; QUALITATIVE RESEARCH; TIME FACTORS; YOUNG ADULT;

EID: 84969204404     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2016.04.012     Document Type: Article

References (24)

1. [1] Hatcher, R.A., Trussell, J., Nelson, A.L., Cates, W., Stewart, F., Contraceptive technology. 19th ed., 2008, Ardent Media, New York.
2. [2] Rowe, P., Boccard, S., Farley, T., Peregoudov, S., Long-term reversible contraception — twelve years of experience with the Tcu380a andTcu220c. Contraception 56 (1997), 341–352.
3. [3] Peipert, J.F., Madden, T., Allsworth, J.E., Secura, G.M., Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol 120 (2012), 1291–1297.
4. [4] Blumenthal, P.D., Voedisch, A., Gemzell-Danielsson, K., Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception. Hum Reprod Update 17 (2011), 121–137.
5. [5] Trussell, J., Henry, N., Hassan, F., Prezioso, A., Law, A., Filonenko, A., Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception 87:2 (2013), 154–161.
6. [6] American College of Obstetricians and Gynecologists, Committee on Gynecologic Practice, and Long-Acting Reversible Contraception Working Group, ACOG Committee opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol 114 (2009), 1434–1438.
7. [7] Peipert, J.F., Zhao, Q., Allsworth, J.E., Petrosky, E., Madden, T., Eisenberg, D., et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 117 (2011), 1105–1113.
8. [8] Rosenstock, J.R., Peipert, J.F., Madden, T., Zhao, Q., Secura, G.M., Continuation of reversible contraception in teenagers and young women. Obstet Gynecol 120 (2012), 1298–1305.
9. [9] Grunloh, D.S., Casner, T., Secura, G.M., Peipert, J.F., Madden, T., Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol 122:6 (2013), 1214–1221.
10. [10] Aoun, J., Dines, V.A., Stovall, D.W., Mete, M., Nelson, C.B., Gomez-Lobo, V., Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol 123 (2014), 585–592.
11. [11] Dickerson, L.M., Diaz, V.A., Jordan, J., Davis, E., Chirina, S., Goddard, J.A., et al. Satisfaction, early removal, and side effects associated with long-acting reversible contraception. Fam Med 45 (2013), 701–707.
12. [12] Asker, C., Stokes-Lampard, H., Beavan, J., Wilson, S., What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study. J Fam Plann Reprod Health Care 32 (2006), 89–94.
13. [13] Foster, D.G., Karasek, D., Grossman, D., Darney, P., Schwarz, E.B., Interest in using intrauterine contraception when the option of self-removal is provided. Contraception 85 (2011), 257–262.
14. [14] Watkins, E.S., From breakthrough to bust: the brief life of Norplant, the contraceptive implant. J Womens Hist 22 (2010), 88–111.
15. [15] Fraser, I.S., Tiitinen, A., Affandi, B., Brache, V., Croxatto, H.B., Diaz, S., et al. Norplant consensus statement and background review. Contraception 57 (1998), 1–9.
16. [16] Kravitz, R.L., Callahan, E.J., Paterniti, D., Antonius, D., Dunham, M., Lewis, C.E., Prevalence and sources of patients’ unmet expectations for care. Ann Intern Med 125 (1996), 730–737.
17. [17] Miller, W.L., Crabtree, B.F., Qualitative analysis: how to begin making sense. Fam Pract Res J 14 (1994), 289–297.
18. [18] Strauss, A.L., Corbin, J.M., Basics of qualitative research: techniques and procedures for developing grounded theory. 2nd ed., 1998, Sage Publications, Thousand Oaks.
19. [19] NVivo qualitative data analysis software. 2012, QSR International Pty Ltd. [Version 10].
20. [20] Dehlendorf, C., Tharayil, M., Anderson, N., Gbenedio, K., Wittman, A., Steinauer, J., Counseling about IUDs: a mixed-methods analysis. Perspect Sex Reprod Health 46:3 (2014), 133–140.
21. [21] Hoggart, L., Newton, V.L., Dickson, J., “I think it depends on the body, with mine it didn't work”: explaining young women's contraceptive implant removal. Contraception 88 (2013), 636–640.
22. [22] Dehlendorf, C., Ruskin, R., Grumbach, K., Vittinghoff, E., Bibbins-Domingo, K., Schillinger, D., et al. Recommendations for intrauterine contraception: a randomized trial of the effects of patients’ race/ethnicity and socioeconomic status. Am J Obstet Gynecol, 203, 2010, 319 319.e1–8.
23. [23] Higgins, J.A., Celebration meets caution: LARC's boons, potential busts, and the benefits of a reproductive justice approach. Contraception 89 (2014), 237–241.
24. [24] Gomez, A.M., Fuentes, L., Allina, A., Women or LARC first? Reproductive autonomy and the promotion of long-acting reversible contraceptive methods. Perspect Sex Reprod Health 46 (2014), 171–175.